TSLP and leukemia: Finally, using our novel +TSLP patient-derived-xenograft (PDX) mouse model [29], we showed that high doses of TSLP prevented the engraftment of primary CRLF2 B-ALL cells, decreased the leukemia burden, and prolonged the survival of CRLF2 B-ALL xenograft mice.